#9,176,146 (11/03/15) Methods of Treating Autism Spectrum Disorders and Compositions for Same.
#9,050,275 (06/09/15) Methods of Screening for and Treating Autism Spectrum Disorders and Compositions for Same.
#5,250,529 (10/05/93) Method of alleviating migraine headache with mast cell degranulation blocking agents.
#5,648,350 (07/15/97) Method of treatment of endogenous, painful gastrointestinal conditions of non-ulcerative
#5,821,259 (10/13/98) Histamine-3 receptor agonists as therapeutic agents.
#5,855,884 (01/05/99) Treatment of stress-induced migraine headache with a corticotropin releasing hormone bl
#5,994,357 (11/30/99) Method of treatment of interstitial cystitis.
#6,020,305 (02/01/00) Treatment of stress-induced skin diseases by CRH antagonists and mast cell inhibitors.
#6,689,748 (02/10/04) Method of treating mast cell activation-induced diseases with a proteoglycan.
#7,759,307 (3/30/04) A method of treating niacin-induced flush.
#10/166,088 (filed 06/11/02) Method of treating IL-6-mediated inflammatory diseases.
#11/214,831 (Filed 8/31/05) Method of treating multiple sclerosis. ALLOWED
#12/151,268 (Filed 5/2/08 Method for treating niacin-induced flush syndromes …
#12/534,571 (Filed 3/8/09) Method of treating an autism spectrum disorder.
#61/405,414 (filed 10/21/10) Extracellular mitochondria-based screening and treatment.
#8,268,365 (09/18/12) Anti-inflammatory Compositions for Treating Brain Inflammation.
#6,624,148 (09/23/03) Proteoglycan compositions for treatment of cardiovascular inflammatory diseases.
#6,635,625 (10/21/03) Proteoglycan compositions for treating prostate and bladder inflammatory conditions.
#6,641,806 (11/04/03) Proteoglycan compositions for treating arthritic inflammation conditions.
#6,645,482 (11/11/03) Proteoglycan compositions for the treatment of arthritic inflammatory diseases.
#6,984,667 (1/10/06) Synergistic proteoglycan compositions for treatment of inflammatory diseases.
# 7,155,278 (10/3/06) Compositions for oral use for treatment of cardiovascular inflammatory diseases.
#7,799,766 (9/21/10) Composition for treatment of hormone-dependent cancers.
#7,906,153 (3/15/11) Anti-inflammatory composition for treating multiple sclerosis.
#8,268,365 (9/18/2012) Pharmaceutical compositions for protecting against superficial flush syndromes.
#8,268,365 (9/18/12) Anti-inflammatory compositions for treating brain inflammation.
#13/112,675 (Filed 5/23/11) Compositions for protecting against superficial vasodilator flush syndrome. and methods of use
EPO # 0618796 (6/5/99) Alleviating or preventing of migraine headache with mast cell degranulation blocking agents.
France, Germany (6922912.5), Ireland, Italy, Netherlands, Spain, United Kingdom
New Zealand #246748 (13/7/00) Method for alleviating or preventing migraine headache onset with mast cell degr
Australia #672,772 (4/4297) Method for alleviating or preventing migraine headache onset with mast cell degranulatio
EPO # 0748217 (7/8/02) Compositions comprising a mast cell degranulation-blocking agents for treatment of endo non-ulcerative origin
France, Germany (69722809.6), Greece, Ireland, Italy, Netherlands, Spain, United Kingdom
EPO # 0618796 (11/6/03) Treatment of stress-induced skin diseases by corticotropin-releasing hormone antagonists
France, Germany (69722809.6), Ireland, Italy, Spain, United Kingdom
EPO # 1365777 (4/19/06) Proteoglycan compositions for the treatment of skin inflammatory diseases.
France, Germany, Greece, Ireland, Italy, Spain, United Kingdom
European Application No. 09743496.3
Based on International Application No. PCT/US09/042888)
Method for protecting humans against superficial vasodilator flush syndrome.
International Application No. PCT/US09/52577
Methods of treating autism spectrum disorders and compositions for same.